Evolution of Patient Perceptions of Psoriatic Disease: Results From the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey

Main Article Content

Mark Lebwohl
Icahn School of Medicine at Mount Sinai, New York, NY, USA

Richard Langley
Division of Dermatology, Department of Medicine, Dalhousie University, Halifax, Canada

Carle Paul
Paul Sabatier University, Toulouse, France

Lluis Puig
Hospital de la Santa Creu I Sant Pau, Barcelona, Spain

Kristian Reich
Center for Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Peter van der Kerkhof
Department of Dermatology, Radboud University Medical Center, Nijmegan, Netherlands

Lihua Tang
Amgen Inc., Thousand Oaks, CA, USA

Sven Richter
Amgen Inc., Thousand Oaks, CA, USA

Benolt Guerette
Amgen Inc., Thousand Oaks, CA, USA

Paolo Gisondi
University Hospital of Verona, Verona, Italy

Keywords

Psoriasis, Chronic Plaque Psoriasis, Perception

Abstract

Abstract not available.

References

1. Lebwohl MG, et al. J Am Acad Dermatol. 2014;70:871-881.

2. van de Kerkhof PC, et al. J Eur Acad Dermatol Venereol. 2015;29:2002-2010.

3. Otezla [package insert]. Thousand Oaks, CA: Amgen, Inc; 2020.

4. Ilumya [package insert]. Whitehouse Station, NJ: Merck & Co Inc; 2018.

5. Tremfya [package insert]. Horsham, PA: Janssen Biotech, Inc; 2017.

6. Lebwohl MG, et al. Am J Clin Dermatol. 2016;17:87-97.

Article Sidebar

Poster PDF
Published
Jan 1, 2021
DOI https://doi.org/10.25251/skin.5.supp.32

Article Details

How to Cite
[1]
Lebwohl, M., Langley, R., Paul, C., Puig, L., Reich, K., van der Kerkhof, P., Tang, L., Richter, S., Guerette, B. and Gisondi, P. 2021. Evolution of Patient Perceptions of Psoriatic Disease: Results From the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey. SKIN The Journal of Cutaneous Medicine. 5, 1 (Jan. 2021), s32. DOI:https://doi.org/10.25251/skin.5.supp.32.
Issue
Vol. 5 No. 1 (2021): January Issue & Poster Presentations (WC21 Dermatology Conference®)
Section
Poster Presentations from FC23 Dermatology Conference®: Psoriasis
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)

<< < 1 2 3 4 5 6 7 8 9 10 > >>